Camber Capital Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-250,000
Closed -$9.18M 37
2018
Q1
$9.18M Buy
250,000
+125,000
+100% +$4.55M 0.45% 30
2017
Q4
$4.69M Buy
+125,000
New +$6.36M 0.23% 32

Other funds holding PRTA

Camber Capital Management's PRTA Position: Q2 2018 in Review

Camber Capital Management sold out of Prothena Corp (PRTA) in Q2 2018, closing a stake of 250,000 shares — an estimated $9.18M sold.

Camber Capital Management first reported a position in PRTA in Q4 2017 and held it in 2 quarters. The position peaked at $9.18M in Q1 2018. 125 funds tracked by Wall St. Rank hold PRTA as of Q2 2018.

  • Camber Capital Management reported no remaining Prothena Corp position as of Q2 2018 after selling out during the quarter.
  • Camber Capital Management sold 250,000 Prothena Corp shares in Q2 2018, an estimated $9.18M.
  • Camber Capital Management first reported a position in Prothena Corp in Q4 2017 and held it in 2 quarters.
  • Camber Capital Management's Prothena Corp position peaked at $9.18M in Q1 2018.
  • 125 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2018.

Based on Camber Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.